Switch to:
Progenics Pharmaceuticals Inc (NAS:PGNX)
Cash And Cash Equivalents
$85.35 Mil (As of Jun. 2014)

Progenics Pharmaceuticals Inc's quarterly cash and cash equivalents increased from Dec. 2013 ($65.86 Mil) to Mar. 2014 ($94.04 Mil) but then declined from Mar. 2014 ($94.04 Mil) to Jun. 2014 ($85.35 Mil).

Progenics Pharmaceuticals Inc's annual cash and cash equivalents declined from Dec. 2011 ($70.11 Mil) to Dec. 2012 ($58.84 Mil) but then increased from Dec. 2012 ($58.84 Mil) to Dec. 2013 ($65.86 Mil).


Definition

Cash and cash equivalents on banks book.


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Progenics Pharmaceuticals Inc Annual Data

Dec04Dec05Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13
BS_CashAndCashEquivalents 5.2367.0711.9510.4256.1990.9047.9270.1158.8465.86

Progenics Pharmaceuticals Inc Quarterly Data

Mar12Jun12Sep12Dec12Mar13Jun13Sep13Dec13Mar14Jun14
BS_CashAndCashEquivalents 56.1047.8241.1058.8455.2879.2275.6065.8694.0485.35
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK